QBT-006

N/A

Report date: 2025/01/21 15:03:06
NME

Base Information

Drug NameQBT-006
Drug Alias NameQBT006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver DiseasesCholangitis, Sclerosing +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQing Bile Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Qingbai Xinda Pharmaceutical Technology Co LtdQing Bile Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver DiseasesCholangitis, Sclerosing +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A